AI assistant
Sending…
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2019
Jul 12, 2019
30583_dirs_2019-07-11_c00cfde5-cc2e-4867-92a0-fbd7b546b2fa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2019-07-09
Reporting Person: ANDERSON ELIZABETH M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-09 | Common Stock | A | 4490 | — | Acquired | 4490 | Direct |
Footnotes
F1: Restricted stock units granted on July 9, 2019 represent a pro rata share of the 2019 annual award for independent directors and vest on June 4, 2020, the same vesting date for the 2019 annual award for all other independent directors.
More from BIOMARIN PHARMACEUTICAL INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Interim / Quarterly Report
2026
May 5
Report Publication Announcement
2026
May 4
M&A Activity
2026
Apr 27
M&A Activity
2026
Apr 23
Annual Report
2026
Apr 21
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19
Director's Dealing
2026
Mar 19